The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment
Authors:
- Frank EngelsmannFEFrank Engelsmann
- Veena DharVDVeena Dhar
- Daniel FilipiniDFDaniel Filipini
- Robert KellerRKRobert Keller
- Guy ChouinardGCGuy Chouinard
- Beverley E. Pearson MurphyBMBeverley E. Pearson Murphy
- 1 March 1995
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 37 (6) , 369-375
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Pathophysiologic Significance of Hyperadrenocorticism: Antiglucocorticoid StrategiesPsychiatric Annals, 1993
- Treatment of major depression with steroid suppressive drugsThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- The clinical meaning of refractory depression: a review for the clinicianAmerican Journal of Psychiatry, 1991
- Steroids and depressionThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brainPsychoneuroendocrinology, 1991
- Aminoglutethimide and ketoconazole: Historical perspectives and future prospectsJournal of Steroid Biochemistry, 1988
- The Use of Ketoconazole as an Inhibitor of Steroid ProductionNew England Journal of Medicine, 1987
- Metyrapone in long-term management of Cushing's disease.BMJ, 1977
- Aminoglutethimide (Elipten® CIBA)—A New Inhibitor of Steroid BiosynthesisAnnals of Internal Medicine, 1969
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960